A1.40 Adiponektin and resistin levels in pregnant patients with rheumatoid arthritis

Akermann, Eva; Tham, Manuela; Förger, Frauke (2014). A1.40 Adiponektin and resistin levels in pregnant patients with rheumatoid arthritis. Annals of the rheumatic diseases, 73(Suppl 1), A17.1-A17. BMJ Publishing Group 10.1136/annrheumdis-2013-205124.39

[img] Text
A17.1.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (84kB) | Request a copy

BACKGROUND

Pregnancy induces a modulation of the maternal immune system in order to install tolerance towards the semiallogeneic fetus. This change of the maternal immune systems influences some autoimmune diseases such as rheumatoid arthritis (RA) in a positive way. Our previous study showed that genes of the adipocytokine pathway were differently regulated by pregnancy as well as by RA. The objective of this study was to analyse the association between pregnancy induced improvement of RA and changes of adipocytokine levels.

MATERIAL AND METHODS

Adiponectin and resistin levels were measured in sera of pregnant (n = 29) and non-pregnant (n = 24) RA patients as well as in pregnant (n = 26) and non-pregnant (n = 9) healthy controls by ELISA. Pregnant RA patients were analysed before conception, once at each trimester and 8 weeks postpartum. Disease activity was measured by CRP and DAS28-CRP.

RESULTS

Resistin levels were higher in non-pregnant RA patients than in healthy controls. Resistin levels increased during pregnancy and decreased postpartum in both healthy subjects and RA patients. However, RA patients with active disease during pregnancy showed higher resistin levels at the third trimester than healthy women. There was a positive correlation between resistin levels and CRP. Adiponektin levels increased at the second trimester of pregnancy and decreased thereafter in both healthy subject and RA patients. There was no difference between patients and healthy subjects. Adiponektin levels of RA patients negatively correlated with CRP.

CONCLUSION

Pregnancy induces an increase of both the resistin and the adiponectin levels. Resistin levels are further influenced by active disease. By contrast, the increase of the adiponectin levels at the second trimester might play a role in the modulation of disease activity of RA.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Tham, Manuela, Förger, Frauke

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0003-4967

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Stefan Kuchen

Date Deposited:

07 Mar 2014 03:23

Last Modified:

05 Dec 2022 14:29

Publisher DOI:

10.1136/annrheumdis-2013-205124.39

PubMed ID:

24489153

Additional Information:

Published Abstract

BORIS DOI:

10.7892/boris.42838

URI:

https://boris.unibe.ch/id/eprint/42838

Actions (login required)

Edit item Edit item
Provide Feedback